Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
暫譯: 納米技術、納米醫學與人工智慧時代的全球健康照護等價性

Boehm, Frank J., Bawa, Raj

Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence

相關主題

商品描述

This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure quantum-encrypted blockchains to create an equitable and decentralized healthcare framework accessible to all people worldwide.

Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence provides insights into how emerging technologies can transform global healthcare delivery through detailed analyses of quantum encryption, blockchain implementation, and AI-driven diagnostics. The book presents a comprehensive roadmap for achieving healthcare equity, offering practical frameworks for technological integration, ethical considerations for implementation, and strategies for overcoming geopolitical barriers to create a truly universal healthcare system.

This visionary work is essential reading for healthcare policy makers, medical technology researchers, AI and quantum computing specialists, global health advocates, and graduate students in healthcare administration, biomedical engineering, and international development. It will particularly benefit professionals working at the intersection of healthcare and emerging technologies who seek to address global health disparities.

商品描述(中文翻譯)

這本開創性的著作探討了一個由人工智慧和量子計算技術驅動的全球健康照護等價系統（Global Health Care Equivalency, GHCE）的願景，該系統運行在安全的量子加密區塊鏈上，旨在創造一個公平且去中心化的健康照護框架，使全球所有人都能夠獲得。

《在奈米技術、奈米醫學和人工智慧時代的全球健康照護等價性》提供了有關新興技術如何通過對量子加密、區塊鏈實施和人工智慧驅動的診斷進行詳細分析來改變全球健康照護交付的見解。這本書提出了一個全面的路線圖，以實現健康照護公平，提供技術整合的實用框架、實施的倫理考量，以及克服地緣政治障礙以創建真正普遍的健康照護系統的策略。

這部具前瞻性的作品是健康照護政策制定者、醫療技術研究人員、人工智慧和量子計算專家、全球健康倡導者，以及健康照護管理、生物醫學工程和國際發展研究的研究生必讀的書籍。它將特別惠及那些在健康照護與新興技術交匯處工作的專業人士，幫助他們解決全球健康差距問題。

作者簡介

Frank J. Boehm has worked as a nanotechnology consultant, technology scout, product designer, research associate, and academic writer/editor for international corporations and university laboratories. Self-taught in nanotechnology and nanomedicine, Frank has developed numerous concepts for advanced nanomedical diagnostic and therapeutic systems. In 2009, he founded NanoApps Medical, Inc. to develop innovative and cost-effective nanomedical solutions for global benefit, and later co-founded NanoApps Athletics, Inc. in 2019. His published works include his first book on nanomedical device design (2013), multiple book chapters, journal articles, and an in-depth paper on "Human Brain/Cloud Interface." Currently, Frank is focused on a three-book series exploring the convergence of nanotechnology, nanomedicine, AI, and quantum computing to achieve global healthcare equivalency.

Raj Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm founded in 2002. Trained as a microbiologist and biochemist, he serves as a registered patent agent, scientific advisor to Teva Pharmaceutical Industries (since 2010), professor at Northern Virginia Community College (since 2004), and vice president/chief IP officer at Guanine, Inc. (since 2016). Dr. Bawa previously worked at the US Patent & Trademark Office (1990s-2002) as a primary examiner. He has led various research initiatives, including a CDC grant to develop an assay for carbapenemase-resistant bacteria. His education includes degrees in microbiology (BSc), cancer biology (MS), biophysics/biochemistry (PhD), and medicine (MD). Currently, he co-chairs nanotech and precision medicine committees for the American Bar Association and serves as founding director of the American Society for Nanomedicine. His contributions include over 100 publications, 10 edited texts, and editorial board service for numerous journals. His achievements have been recognized with awards including the Innovations Prize (2008), Appreciation Award from the Undersecretary of Commerce (2001), and Lifetime Achievement Award from the American Society for Nanomedicine (2014).

作者簡介(中文翻譯)

**Frank J. Boehm** 曾擔任納米技術顧問、技術偵查員、產品設計師、研究助理以及國際企業和大學實驗室的學術作家/編輯。Frank 是自學的納米技術和納米醫學專家，開發了多個先進的納米醫療診斷和治療系統的概念。2009年，他創立了 NanoApps Medical, Inc.，以開發創新且具成本效益的納米醫療解決方案，造福全球，並於2019年共同創立了 NanoApps Athletics, Inc.。他的出版作品包括2013年發表的第一本納米醫療設備設計書籍、多個書籍章節、期刊文章，以及一篇深入探討「人腦/雲端介面」的論文。目前，Frank 專注於一個三本書系列，探索納米技術、納米醫學、人工智慧和量子計算的融合，以實現全球醫療平等。

**Raj Bawa** 是 Bawa Biotech LLC 的總裁，這是一家成立於2002年的生技/製藥顧問和專利法律事務所。他接受微生物學和生物化學的訓練，擔任註冊專利代理人、Teva Pharmaceutical Industries 的科學顧問（自2010年起）、北維吉尼亞社區學院的教授（自2004年起），以及 Guanine, Inc. 的副總裁/首席知識產權官（自2016年起）。Bawa 博士曾在美國專利商標局（1990年代至2002年）擔任主要審查員。他領導了多項研究計畫，包括一項CDC的補助金，用於開發針對碳青霉烯酶抗性細菌的檢測。他的學歷包括微生物學（學士）、癌症生物學（碩士）、生物物理/生物化學（博士）和醫學（醫學博士）學位。目前，他共同主持美國律師協會的納米技術和精準醫療委員會，並擔任美國納米醫學學會的創始主任。他的貢獻包括超過100篇出版物、10本編輯文本，以及多本期刊的編輯委員會服務。他的成就獲得了多項獎項，包括創新獎（2008年）、商務部副部長的感謝獎（2001年）和美國納米醫學學會的終身成就獎（2014年）。

類似商品

最後瀏覽商品 (3)